Healthcare provider profile · identity verified

Mohammed Solaiman, MD

Family Practice · SAINT PETER, MN · NPI 1174507149

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	505	140
Amlodipine Besylate	Amlodipine Besylate	450	121
Metoprolol Succinate	Metoprolol Succinate	435	120
Lisinopril	Lisinopril	401	109
Losartan Potassium	Losartan Potassium	342	98
Rosuvastatin Calcium	Rosuvastatin Calcium	310	86
Levothyroxine Sodium	Levothyroxine Sodium	293	70
Tamsulosin Hcl	Tamsulosin Hcl	252	71
Omeprazole	Omeprazole	217	68
Gabapentin	Gabapentin	170	49
Furosemide	Furosemide	163	48
Jardiance	Empagliflozin	156	43
Eliquis	Apixaban	146	31
Pantoprazole Sodium	Pantoprazole Sodium	145	49
Hydrochlorothiazide	Hydrochlorothiazide	144	46
Metformin Hcl	Metformin Hcl	143	36
Sertraline Hcl	Sertraline Hcl	141	43
Simvastatin	Simvastatin	129	41
Warfarin Sodium	Warfarin Sodium	117	30
Allopurinol	Allopurinol	105	28
Alendronate Sodium	Alendronate Sodium	102	24
Metoprolol Tartrate	Metoprolol Tartrate	99	32
Metformin Hcl Er	Metformin Hcl	95	26
Pravastatin Sodium	Pravastatin Sodium	92	24
Bupropion Xl	Bupropion Hcl	89	18
Albuterol Sulfate Hfa	Albuterol Sulfate	85	30
Spironolactone	Spironolactone	85	23
Fluticasone Propionate	Fluticasone Propionate	83	34
Escitalopram Oxalate	Escitalopram Oxalate	82	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	21
Carvedilol	Carvedilol	77	20
Jantoven	Warfarin Sodium	73	suppressed
Glimepiride	Glimepiride	72	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	70	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	23
Donepezil Hcl	Donepezil Hcl	64	14
Mounjaro	Tirzepatide	63	12
Atenolol	Atenolol	62	13
Ezetimibe	Ezetimibe	61	17
Ozempic	Semaglutide	60	12
Trazodone Hcl	Trazodone Hcl	58	16
Finasteride	Finasteride	57	17
Potassium Chloride	Potassium Chloride	52	18
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	45	13
Propranolol Hcl	Propranolol Hcl	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	13
Tramadol Hcl	Tramadol Hcl	43	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	13
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	40	38
Memantine Hcl	Memantine Hcl	40	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Famotidine	Famotidine	37	15
Duloxetine Hcl	Duloxetine Hcl	34	15
Glipizide Er	Glipizide	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Torsemide	Torsemide	33	16
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	32	suppressed
Ketoconazole	Ketoconazole	32	24
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Nitroglycerin	Nitroglycerin	31	26
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Nystatin	Nystatin	28	13
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Prednisone	Prednisone	22	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Dulera	Mometasone/Formoterol	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Azithromycin	Azithromycin	18	15
Digoxin	Digoxin	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Amoxicillin	Amoxicillin	17	15
Clonidine Hcl	Clonidine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Single Use Swab	Alcohol Antiseptic Pads	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Sotalol	Sotalol Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ramipril	Ramipril	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Topiramate	Topiramate	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error